Prof. Neal A.Ready
Prof. Neal A.Ready

Member of the Duke Cancer Institute

CheckMate 568 Clinical Trial Principal Investigator (First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer) 

CONDOR Randomized Clinical Trial Investigator (Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC)

Important Links
Contact Information
Sign up for Newsletter
Copyright © reserved to BGICC 2021
Created by KEYFrame